InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
13
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Segal Lloyd Mitchell, Chairman & CEO. Insider active across 1 company, notably Repare Therapeutics Inc.. Aggregated, 16 filings have been recorded. Split: 0 buy · 13 sells. Total volume traded: €895k. Activity tracked since 18 May 2021. The latest transaction was filed on 12 March 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations16 total
21,179 shares@ US$1.142.5% of flowCommon SharesSEC:0001415889-25-008105:0
40,000 shares0Common SharesSEC:0001415889-25-007239:0
2,650 shares@ US$4.621.3% of flowCommon SharesSEC:0001415889-24-009629:0
2,650 shares@ US$4.791.3% of flowCommon SharesSEC:0001415889-24-009249:0
40,000 shares0Common SharesSEC:0001415889-24-006464:0
78,550 shares0Common SharesSEC:0001209191-23-006062:0
1,542 shares@ US$35.615.1% of flowCommon StockSEC:0001209191-21-044032
1,542 shares@ US$35.615.4% of flowCommon StockSEC:0001209191-21-044032:0
1,576 shares@ US$35.005.3% of flowCommon StockSEC:0001209191-21-039621:0
1,576 shares@ US$35.005.1% of flowCommon StockSEC:0001209191-21-039621
6,648 shares@ US$31.7420.5% of flowCommon StockSEC:0001209191-21-038747:0
6,648 shares@ US$31.7419.4% of flowCommon StockSEC:0001209191-21-038747
3,770 shares@ US$35.030612.7% of flowCommon StockSEC:0001209191-21-034874
3,770 shares@ US$35.030612.7% of flowCommon StockSEC:0001209191-21-034874:0
1,800 shares@ US$35.006.1% of flowCommon StockSEC:0001209191-21-034571
1,800 shares@ US$35.006.1% of flowCommon StockSEC:0001209191-21-034571:0
16 of 16 declarations
About Segal Lloyd Mitchell
Lloyd Mitchell Segal is the President and CEO of Repare Therapeutics Inc. He leads the company in its efforts to develop innovative therapies in the biotechnology field.
